Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Stannous Fluoride Dentifrice for Dentinal Hypersensitivity
NCT02832375Phase 3Completed
- Sponsor
- GSK
- Start
- Mar 2016
- Primary completion
- May 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of stannous fluoride in dentin hypersensitivity (DH), sponsored by GSK. Started Mar 2016; status: completed.
02
Drugs
stannous fluoride
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT02832375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02832375.